- Home
- DMA vs FORA Comparison
DMA vs FORA Comparison
Compare DMA & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DMA | FORA |
|---|---|---|
| Founded | N/A | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Computer Software: Prepackaged Software |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.4M | 67.3M |
| IPO Year | 2011 | 2020 |
Fundamental Metrics
Financial Performance| Metric | DMA | FORA |
|---|---|---|
| Price | $7.43 | $2.16 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 27.7K | ★ 42.0K |
| Earning Date | 01-01-0001 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 25.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $30,256,919.00 |
| Revenue This Year | N/A | $8.44 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 50.13 |
| 52 Week Low | $7.27 | $1.64 |
| 52 Week High | $9.15 | $2.71 |
Technical Indicators
Market Signals| Indicator | DMA | FORA |
|---|---|---|
| Relative Strength Index (RSI) | 30.27 | 62.61 |
| Support Level | $7.27 | $2.05 |
| Resistance Level | $8.89 | $2.20 |
| Average True Range (ATR) | 0.22 | 0.01 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 10.58 | 66.67 |
Price Performance
Historical ComparisonAbout DMA Destra Multi-Alternative Fund
Destra Multi-Alternative Fund is a non-diversified, closed-end management investment company that operates as an interval fund with a continuous offering of fund shares. The investment objective of the fund is to seek returns from capital appreciation and income with an emphasis on income generation.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.